PETQ News and Press, PetIQ Inc. From 03/09/23

2023-03-09 08:22:47 ET Summary Patterson Companies has had a rather mixed operating history in recent years, with sales climbing, but profits and cash flows posting volatile results. That trend has continued into the 2023 fiscal year, though cash flow data is looking up. The f...

2023-03-05 12:48:39 ET Summary Petco Health and Wellness Company has not fared all that well compared to the broader market. This comes even as sales continue to climb and as bottom line results are mixed but still positive. Shares are cheap and do seem to offer attractive ups...

Gainers: Reata Pharmaceuticals ( RETA ) +176% . OncoSec Medical ( ONCS ) +118% . Sarepta Therapeutics ( SRPT ) +24% . PetIQ ( PETQ ) +17% . Amphastar Pharmaceuticals ( AMPH ) +15% . Losers: Novavax ( NVAX ) -24% . ...

PetIQ, Inc. (PETQ) Q4 2022 Earnings Conference Call February 28, 2023, 04:30 PM ET Company Participants Katie Turner - Investor Relations McCord Christensen - Chairman & Chief Executive Officer Zvi Glasman - Chief Financial Officer Michael Smith - President &am...

PetIQ press release ( NASDAQ: PETQ ): Q4 Non-GAAP EPS of -$0.10 misses by $0.06 . Revenue of $184.08M (-6.4% Y/Y) misses by $8.38M . Product segment net sales of $157.3 million and Services segment net revenues of $26.8 million Net sales for PetIQ’s manufact...

Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Qua...

PetIQ ( NASDAQ: PETQ ) is scheduled to announce Q4 earnings results on Tuesday, February 28th, after market close. The consensus EPS Estimate is -$0.04 (+91.8% Y/Y) and the consensus Revenue Estimate is $192.46M (-2.1% Y/Y). Over the last 2 years, PETQ has beaten EPS estimat...

EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, on Tuesd...

Summary Robust financial results from the previous quarter, driven by end-market demand and e-commerce sales channels. Fundamental momentum gathering with profitability a standout last period from strong sales growth. Technicals equally supportive of further upside capture. Rate...

Class A shares of micro-cap pet medication and wellness company PetIQ ( NASDAQ: PETQ ) jumped 32.2% to $9.46 in Thursday morning trading, after it reported a Q3 results beat and raised its FY 2022 adj. EBITDA guidance. It is worth noting that PETQ stock had already been ...